Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-063297

SVP & Chief Scientific Officer acquired 23,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doberstein Stephen K SVP & Chief Scientific Officer 2018-12-14 Grant or award +23,950 102,684 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Doberstein Stephen K SVP & Chief Scientific Officer 2018-12-14 Grant or award · Stock Option +48,400 48,400 D: show line 2 in the form
Loading xslF345X03/doc4.xml…